AMAG PHARMACEUTICALS (AMAG) analyst actions
Rating and price-target actions on AMAG in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the AMAG overview →
No AMAG analyst action events in the measured window.
Nothing matched in the current window — the AMAG overview has every event we measure for this name.
Get an email when AMAG moves on news →Keep exploring
More AMAG: earnings → · SEC filings → · AMAG overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| BioDelivery Sciences International, Inc. (BDSI) | 1,059 | 0.00% | 47% |
| Integer Holdings Corporation (ITGR) | 1,059 | 0.00% | 49% |
| Dicerna Pharmaceuticals, Inc. (DRNA) | 1,055 | +0.03% | 51% |
| Arena Pharmaceuticals, Inc. (ARNA) | 1,052 | 0.00% | 47% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.